2022 annual financial data
Immuneering 2022 Financial results
Direct answer
Revenue was 316,952 USD.
Operating income was -51,744,868 USD and net income was -50,513,568 USD.
Operating cash flow was -44,101,265 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 316,952 USD
- Operating income
- -51,744,868 USD
- Net income
- -50,513,568 USD
- Operating cash flow
- -44,101,265 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immuneering financial years